Monkeypox

Titles

All titles Clinical Sense Prognosis: Your Diagnosis Explain Medicine QBank Prepper

Library

Core specialties Subspecialties Organ systems Cutting edge innovations

Library

Core specialties Subspecialties Organ systems Cutting edge innovations

About Clinical Odyssey

Why trust us Pricing Subscribe For organizations

Editorial

Authors Peer reviewers

Medical Joyworks, LLC

About Jobs Contact

Read Discuss

Hi there!

You’re looking at a short reference article from Explain Medicine (one of four distinct learning formats available in Clinical Odyssey). Try it out, and have fun improving your clinical skills.

Medicine

Last updated on:
August 21^st, 2023

Medicine

Last updated on:
August 21^st, 2023

Hi there!

You’re looking at a short reference article from Explain Medicine (one of four distinct learning formats available in Clinical Odyssey). Try it out, and have fun improving your clinical skills.

Introduction

Fact	Explanation
Epidemiology	Human monkeypox (MPX) is a zoonotic disease caused by the monkeypox virus (MPXV). It is an endemic disease in the tropical rainforest regions of Central and West Africa. In non-endemic countries, sporadic travel and animal-related cases were reported until the most recent ongoing outbreak worldwide.
Virology	MPXV belongs to the Orthopoxvirus genus of the Poxviridae family; it is an enveloped double-stranded DNA. There are two phylogenetically distinct clades of MPXV, the Central African clade (CAC), which is associated with a more severe and transmissible disease, and the West African clade (WAC). Squirrels, rats, and non-human primates have been identified as natural hosts of MPXV. However, the exact reservoir of monkeypox has not yet been identified. The WAC is responsible for the multi-country outbreaks in non-endemic countries in 2022. Smallpox, vaccinia, cowpox, horsepox and Cantagaio viruses are also part of the Orthopoxvirus genus. Viruses belonging to this genus show reactivity and cross-protection. Monkeypox was isolated from research animals in Denmark in 1958. In 1970, the first human cases were described.
Transmission	MPXV is typically acquired through contact with an infected animal's bodily fluids or through a bite. Human-to-human transmission most often occurs through direct contact with infectious sores, scabs, or body fluids; indirect contact can occur via contact with materials or fomites contaminated with infected material. The virus enters the body also through the respiratory tract or the mucous membranes but prolonged face-to-face contact is required for the transmission via droplet respiratory particles. Vertical transmission (congenital) can also occur. After the incubation period, transmissibility occurs from the beginning of symptoms and goes until the crusts disappear, which can be up to 28 days.
Immunocompromised patients	Little information is available on MPX in immunocompromised patients but it seems that they may be at increased risk of worse outcomes.
Outbreaks	MPX is a disease of global public health importance. The first outbreak outside Africa was reported in the United States of America in 2003. In May 2022 an unprecedented outbreak was first reported in Europe. Community-based transmission has been widespread across many countries worldwide and mainly in men who have sex with men (MSM), leading to the hypothesis that MPX may be spread via sexual activity.
Course of disease	The interval from infection to onset of symptoms (incubation period) of MPX is most often 6 to 13 days but can range from 5 to 21 days. The infection is divided in two phases: the prodromal period and skin eruptions.
Prevention	Reducing the risk of human-to-human transmission, reducing the risk of zoonotic transmission, and preventing monkeypox through restrictions on animal trade are the main infection prevention strategies to reduce exposure to the virus.
Prevention of infection in community and health care settings	In the community setting, the isolation of patients in a separate room, coverage of skin, and wearing a face mask are measures recommended to prevent the spread of infection. Household members should use disposable gloves to minimize the risk of contact with lesions. In the hospital setting, early recognition of patients with suspected MPX, implementation of source control measures (e.g., isolation in a private room) and the use of standard precautions (e.g., hand hygiene, use of personal protective equipment–PPE, and environmental cleaning) are measures recommended to prevent the spread of infection. Health workers providing direct care to MPX patients should wear a face mask along with other PPE that are part of droplet and contact precautions.

Epidemiology

Human monkeypox (MPX) is a zoonotic disease caused by the monkeypox virus (MPXV). It is an endemic disease in the tropical rainforest regions of Central and West Africa. In non-endemic countries, sporadic travel and animal-related cases were reported until the most recent ongoing outbreak worldwide.

Virology

MPXV belongs to the Orthopoxvirus genus of the Poxviridae family; it is an enveloped double-stranded DNA. There are two phylogenetically distinct clades of MPXV, the Central African clade (CAC), which is associated with a more severe and transmissible disease, and the West African clade (WAC). Squirrels, rats, and non-human primates have been identified as natural hosts of MPXV. However, the exact reservoir of monkeypox has not yet been identified. The WAC is responsible for the multi-country outbreaks in non-endemic countries in 2022. Smallpox, vaccinia, cowpox, horsepox and Cantagaio viruses are also part of the Orthopoxvirus genus. Viruses belonging to this genus show reactivity and cross-protection. Monkeypox was isolated from research animals in Denmark in 1958. In 1970, the first human cases were described.

Transmission

MPXV is typically acquired through contact with an infected animal's bodily fluids or through a bite. Human-to-human transmission most often occurs through direct contact with infectious sores, scabs, or body fluids; indirect contact can occur via contact with materials or fomites contaminated with infected material. The virus enters the body also through the respiratory tract or the mucous membranes but prolonged face-to-face contact is required for the transmission via droplet respiratory particles. Vertical transmission (congenital) can also occur. After the incubation period, transmissibility occurs from the beginning of symptoms and goes until the crusts disappear, which can be up to 28 days.

Immunocompromised patients

Little information is available on MPX in immunocompromised patients but it seems that they may be at increased risk of worse outcomes.

Outbreaks

MPX is a disease of global public health importance. The first outbreak outside Africa was reported in the United States of America in 2003. In May 2022 an unprecedented outbreak was first reported in Europe. Community-based transmission has been widespread across many countries worldwide and mainly in men who have sex with men (MSM), leading to the hypothesis that MPX may be spread via sexual activity.

Course of disease

The interval from infection to onset of symptoms (incubation period) of MPX is most often 6 to 13 days but can range from 5 to 21 days. The infection is divided in two phases: the prodromal period and skin eruptions.

Prevention

Reducing the risk of human-to-human transmission, reducing the risk of zoonotic transmission, and preventing monkeypox through restrictions on animal trade are the main infection prevention strategies to reduce exposure to the virus.

Prevention of infection in community and health care settings

In the community setting, the isolation of patients in a separate room, coverage of skin, and wearing a face mask are measures recommended to prevent the spread of infection. Household members should use disposable gloves to minimize the risk of contact with lesions.

In the hospital setting, early recognition of patients with suspected MPX, implementation of source control measures (e.g., isolation in a private room) and the use of standard precautions (e.g., hand hygiene, use of personal protective equipment–PPE, and environmental cleaning) are measures recommended to prevent the spread of infection.

Health workers providing direct care to MPX patients should wear a face mask along with other PPE that are part of droplet and contact precautions.

Want to continue reading?

Subscribe to Clinical Odyssey today.

Enjoy unlimited access to 700+ learning modules.
Safely improve your skills, anytime and anywhere.
Get answers to your follow-up questions from practicing physicians.

Learn more ➜